A novel mutation in DNMT3B gene causing ICF1 syndrome in an infant with refractory thrombocytopenia

• Published in: Clinical immunology (Orlando, Fla.) Fla.), 2023-11, Vol.256, p.109779-109779, Article 109779
• Main Authors: Baris, Savas, Boluk, Selime Ozen
• Format: Article
• Language: English
• Subjects: Autoimmunity; DNMT3B mutation; ICF syndrome
• ISSN: 1521-6616; 1521-7035
• DOI: 10.1016/j.clim.2023.109779

ICF syndrome is a rare autosomal recessive condition characterized by immunodeficiency, centromeric instability, and facial abnormalities. It is a clinical condition that depends on the mutation of a few particular genes and is caused by methylation disruption in chromosomes 1, 9, and 16 to varying degrees. The 9-months old, female patient was admitted to our clinic for treatment-resistant thrombocytopenia, chronic diarrhea and sepsis. Immunological investigations revealed agammaglobulinemia. In the genetic analysis by NGS of the patient, who had dysmorphic facial findings as well as a history of parental consanguinity, it was determined that she had a novel mutation in the DNMT3B gene, which is one of the responsible genes of ICF, as homozygous. The patient, who was started on regular immunoglobulin replacement therapy and antibiotic therapy, was referred to a center with a stem cell transplant unit to continue her follow-up. Although autoimmunity has not been commonly reported in previous studies in ICF syndrome, which has a varied clinical presentation, a homozygous mutation in the DNMT3B gene was discovered in a 9-month-old patient with refractory thrombocytopenia and agammaglobulinemia. Examining the literature reveals that this mutation is a novel mutation. •ICF1 syndrome.•DNMT3B novel mutation.•Immunodeficiency.